Oncology devices market seen reaching $397.27B by 2030

The oncology devices market is projected to grow from $177.72 billion in 2025 to $397.27 billion by 2030, driven by rising cancer cases, broader screening, and more advanced treatment tools. North America held the largest share in 2025, while Asia-Pacific ranked second.

Why it matters: - The oncology devices market sits at the center of cancer screening, diagnosis, treatment, and recovery. - Faster growth in cancer cases is pushing demand for devices that support earlier detection, safer drug delivery, and more precise treatment. - The market’s long-term growth signals continued investment in oncology infrastructure, imaging, and AI-enabled diagnostics.

What happened: - The Business Research Company projected the oncology devices market will rise from $177.72 billion in 2025 to $210.15 billion in 2026. - The same forecast puts the market at $397.27 billion by 2030, representing a 17.3% CAGR from 2026 to 2030. - The company tied the forecast to rising cancer incidence, growth in hospital oncology departments, stronger screening awareness, and wider use of advanced imaging tools. - The report also pointed to growing acceptance of personalized cancer treatment devices, more oncology infrastructure spending, outpatient cancer care expansion, AI-based diagnostic tools, and precision oncology. - The company said North America held the largest market share in 2025, with Asia-Pacific in second place.

The details: - Oncology devices include medical instruments and technologies used across the cancer care continuum. - The devices support early detection, disease monitoring, targeted therapies, and patient outcome improvement. - The market’s recent growth was driven by higher demand for chemotherapy, which depends on safer and more accurate drug delivery systems. - The report cited a January 2025 U.S. National Cancer Institute projection showing new U.S. cancer cases reaching 2.04 million, up from 1.96 million in 2023. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. - The report’s 2026 edition includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology and future trend analysis, and updated graphics and tables. - The company offered a free sample of the report and a full market report online: sample report and full report.

Between the lines: - The forecast suggests oncology devices are shifting from a niche hospital category to a broader, technology-driven care market. - The strongest growth themes are not just more cancer cases, but more sophisticated care pathways, including minimally invasive treatment and image-guided therapy. - The regional split suggests mature markets still dominate spending, while Asia-Pacific is gaining as access to cancer care expands.

What's next: - Market growth is expected to continue through 2030 as providers adopt more precision-focused and AI-assisted tools. - Wider use of outpatient cancer care facilities should support demand for devices that enable efficient, less invasive treatment. - Growth in early detection and advanced radiation systems is likely to remain a central market theme.

The bottom line: - Oncology devices are on a steep growth path, with cancer-care modernization and higher diagnosis rates driving demand through the rest of the decade.